Last updated on October 2020

A Study on Impact of Canagliflozin on Health Status Quality of Life and Functional Status in Heart Failure

Brief description of study

The purpose of this study is to determine the superiority of the effectiveness of canagliflozin 100 milligram (mg) daily versus placebo in participants with symptomatic heart failure (HF) in improving the overall Kansas City Cardiomyopathy Questionnaire (KCCQ) Total Symptom Score (TSS).

Clinical Study Identifier: NCT04252287

Find a site near you

Start Over

MedStar Health Research Institute

Hyattsville, MD United States
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.